AGP Executive Report
Last update: an hour agoGLP-1 Weight-Loss Push in China: Novo Nordisk says it will seek approval for the Wegovy pill in China within weeks or months, aiming to make it one of the first oral GLP-1 weight-loss options in the market. AI in Primary Care: Google’s AMIE diagnostic AI matched or beat primary care physicians across most complex diagnostic measures in a Nature study, including a multimodal version that can assess images and ECGs. Public Health Alerts: Lesotho reported flu-like illness clusters, prompting a health alert and investigations. Ebola Response: China pledged a new round of emergency humanitarian aid to Africa, including support for DRC and supplies for Uganda, as Ebola monitoring ramps up. Traditional Medicine Safety: WHO ran a Macao workshop focused on quality and safety rules for traditional, complementary and integrative medicine to strengthen trust and universal health coverage. India Telegram Crackdown: India temporarily blocked Telegram amid NEET exam fraud concerns; Telegram is challenging the move in court, warning it could restrict free speech for 150M users. Healthcare M&A Momentum: PwC data points to a surge in pharma deals, with big buyers snapping up next-gen therapies as blockbuster patents near expiry. Local Health & Safety: Bengaluru reported a 12-year-old hospitalized after a neighbor’s Rottweiler attack, with police filing negligence-related cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
